Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities (PPC Heart)
Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities: A Pilot Study of the Patient Priorities Care Approach at Cooper Green Mercy Health Services Authority (PPC-HEART)
調査の概要
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前:Nardakafaria McNeill
- 電話番号:205-934-0707
- メール:nmcneill@uab.edu
研究場所
-
-
Alabama
-
Birmingham、Alabama、アメリカ、35233
- 募集
- Cooper Green Mercy Hospital
-
コンタクト:
- Nardakafaria McNeill
- 電話番号:205-934-0707
- メール:nmcneill@uab.edu
-
主任研究者:
- Deborah Ejem, PhD
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- greater than or equal to 50 years old
- at least one CVD (i.e., coronary artery disease, hypertension, heart failure, arrhythmias, cardiomyopathy, peripheral artery disease, stroke, and valvular heart disease)
- at least one coexisting chronic condition (i.e., inflammatory joint disease, COPD/asthma, diabetes, chronic kidney disease, and cancer one-year post-treatment)
- a caregiver of a participant, or a provider who serves this population.
Exclusion Criteria:
- Axis I psychiatric (schizophrenia, bipolar disorder), dementia, suicidal ideation,
- active substance use disorder nursing home or assisted living facility residence.
研究計画
研究はどのように設計されていますか?
デザインの詳細
コホートと介入
グループ/コホート |
|---|
|
Community Advisory Group (CAG) and Pilot Group
Nine of the 29 participants will participate in Aim 1 of the study, which involves convening a focus group to develop a culturally responsive version of the PPC Approach for underserved African Americans. This number was determined based on qualitative research best practices, which suggest that 6-10 participants per focus group allow for a diverse range of perspectives while maintaining an environment conducive to in-depth discussion. Additionally, this sample size aligns with previous studies that successfully used small, targeted focus groups to refine culturally tailored interventions. Twenty patients will participate in the pilot testing of the newly developed culturally responsive version of the PPC Approach. This number was determined to be satisfactory because it provides a sufficient sample to assess the feasibility and acceptability of the intervention while ensuring a manageable study scope. Prior feasibility studies have demonstrated that sample sizes between 15 and 30 par |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Older Patient Assessment of Chronic Illness Care (O-PACIC) Score
時間枠:Baseline and eight weeks post- baseline.
|
Patient experience with integrated care delivery and self-management support measured using the 10-item Older Patient Assessment of Chronic Illness Care (O-PACIC) questionnaire.
Responses to the 10 items will be summed to calculate a total score ranging from 10 to 50.
Higher scores indicate more positive perceptions of chronic illness care.
Scores will be reported at baseline and 8 weeks post-baseline, along with the change from baseline.
|
Baseline and eight weeks post- baseline.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Treatment Burden Questionnaire (TBQ) Score
時間枠:Baseline and eight weeks post- baseline
|
Perceived treatment burden measured using the 13-item Treatment Burden Questionnaire (TBQ).
Each item is rated from 0, indicating not a problem, to 10, indicating a big problem.
Item scores will be summed to calculate a total score ranging from 0 to 130. Higher scores indicate greater perceived treatment burden.
Scores will be reported at baseline and 8 weeks post-baseline, along with the change from baseline.
|
Baseline and eight weeks post- baseline
|
|
Perceived Shared Clinical Decision-Making (CollaboRATE Score)
時間枠:Baseline and eight week post- baseline
|
Patient perception of involvement in shared decision-making measured using the 3-item CollaboRATE questionnaire.
Responses to the three items will be averaged to calculate an overall mean score ranging from 1 to 9. Higher scores indicate greater perceived involvement in shared decision-making.
Scores will be assessed at baseline and 8 weeks post-baseline, and change from baseline will be evaluated.
|
Baseline and eight week post- baseline
|
協力者と研究者
捜査官
- 主任研究者:Deborah Ejem、University of Alabama at Birmingham
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- IRB-300013717
- NIMHD (その他の識別子:National Institute on Minority Health and Health Disparities)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。